Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2022 1
2023 1
2024 5
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Proteomics in Psoriasis: Recent Advances.
Leotsakos G, Katafigiotis I, Leotsakos I, Kousta F, Molympakis A, Perimeni A, Koutsilieris M. Leotsakos G, et al. Among authors: kousta f. In Vivo. 2024 May-Jun;38(3):1000-1008. doi: 10.21873/invivo.13533. In Vivo. 2024. PMID: 38688625 Free PMC article. Review.
Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in patients with plaque psoriasis: results from a real-world multicentre study.
Katoulis A, Papadavid E, Koumprentziotis IA, Rompoti N, Stefanaki I, Panagakis P, Theotokoglou S, Vavouli C, Lampadaki K, Papoutsaki M, Theodoropoulos K, Politou M, Kanelleas A, Befon A, Lazou E, Kousta F, Tzaki M, Chasapi V, Stratigos A, Nicolaidou E. Katoulis A, et al. Among authors: kousta f. Clin Exp Dermatol. 2026 Feb 24;51(3):476-478. doi: 10.1093/ced/llaf492. Clin Exp Dermatol. 2026. PMID: 41205819 No abstract available.
Factitious Disorder as a Skin Ulcer: A Case Report.
Kontoangelos K, Kousta F, Potouridou I, Chasapi V, Dikeos D, Stratigos A. Kontoangelos K, et al. Among authors: kousta f. Cureus. 2024 Jan 4;16(1):e51642. doi: 10.7759/cureus.51642. eCollection 2024 Jan. Cureus. 2024. PMID: 38313954 Free PMC article.
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.
Stefanaki I, Koumprentziotis IA, Rompoti N, Panagakis P, Vavouli C, Papoutsaki M, Politou M, Befon A, Kousta F, Lazou E, Chasapi V, Stratigos A, Nicolaidou E. Stefanaki I, et al. Among authors: kousta f. Int J Dermatol. 2025 Jun;64(6):1098-1100. doi: 10.1111/ijd.17658. Epub 2025 Jan 16. Int J Dermatol. 2025. PMID: 39821776 No abstract available.
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Rompoti N, Vergou T, Stefanaki I, Vavouli C, Koumprentziotis IA, Panagakis P, Papoutsaki M, Politou M, Befon A, Kousta F, Lazou E, Zaimi M, Chasapi V, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: kousta f. Int J Dermatol. 2024 Oct;63(10):e255-e258. doi: 10.1111/ijd.17400. Epub 2024 Jul 25. Int J Dermatol. 2024. PMID: 39051109 No abstract available.
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis.
Rompoti N, Stefanaki I, Panagakis P, Papoutsaki M, Politou M, Vavouli C, Befon A, Kousta F, Lazou E, Zaimi M, Koumprentziotis IA, Chasapi V, Rigopoulos D, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: kousta f. J Eur Acad Dermatol Venereol. 2025 Jan;39(1):e1-e4. doi: 10.1111/jdv.19956. Epub 2024 Mar 20. J Eur Acad Dermatol Venereol. 2025. PMID: 38506605 No abstract available.
11 results